创伤救治级别与临床结局指标的关联:系统综述与荟萃分析
在一般创伤人群中,I级创伤中心与非I级相比院内死亡率无显著差异(aOR 0.97;95%CI 0.61-1.52)。在严重创伤人群中,I级创伤中心与非I级相比院内死亡率更低(aOR 0.77;95%CI 0.69-0.87)。非致命结局因证据不一致无法得出结论。
要点
- 严重创伤(ISS>15)人群:I级创伤中心院内死亡率低于非I级(aOR 0.77;95%CI 0.69-0.87)。
- 一般创伤人群:I级与非I级创伤中心院内死亡率无显著差异(aOR 0.97;95%CI 0.61-1.52)。
- 15项一般创伤研究中9项(60%)报告I级创伤中心有生存获益。
- 11项严重创伤研究中10项(91%)报告I级创伤中心有生存获益。
- 非致命结局因证据不一致,无法证明I级创伤中心的关联。
适用人群与场景
- 一般创伤人群与严重创伤人群(严重创伤优选损伤严重度评分>15)。
- 纳入比较不同创伤救治级别间死亡率或非致命结局的研究;排除标准原文未提及。
诊断标准与关键阈值
- 创伤救治级别分类:I级创伤中心 vs 非I级创伤中心。
- 严重创伤定义:优选损伤严重度评分(Injury Severity Score)>15。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 一般创伤人群:15项分析院内死亡率的研究中9项(60%)报告I级创伤中心有生存获益;I级与非I级相比院内死亡率无显著差异(校正比值比0.97;95%CI 0.61-1.52)。
- 严重创伤人群:11项报告院内死亡率的研究中10项(91%)报告I级创伤中心有生存获益;I级与非I级相比院内死亡率更低(校正比值比0.77;95%CI 0.69-0.87)。
- 非致命结局:因证据不一致,无法证明I级创伤中心的关联。
- 研究质量良好,但对合并症(32%)和院间转运(38%)的校正执行较少。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析。
- 证据等级:level III。
- 局限:研究质量良好,但对合并症(32%)和院间转运(38%)的校正执行较少;非致命结局证据不一致。
对床旁实践的改变
- 严重创伤(ISS>15)人群:I级创伤中心与非I级相比院内死亡率更低(aOR 0.77;95%CI 0.69-0.87),支持严重创伤患者转运至I级创伤中心。
- 一般创伤人群:I级与非I级创伤中心院内死亡率无显著差异(aOR 0.97;95%CI 0.61-1.52),不能据此证明一般创伤患者需集中至I级创伤中心。
- 非致命结局:因证据不一致,无法证明I级创伤中心的关联。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: With implementation of trauma systems, a level of trauma care classification was introduced. Use of such a system has been linked to significant improvements in survival and other outcomes.
OBJECTIVES: The aim of this study was assessing the association between level of trauma care and fatal and nonfatal outcome measures for general and major trauma (MT) populations.
METHODS: A systematic literature search was conducted using six electronic databases up to December 18, 2019. Studies comparing mortality or nonfatal outcomes between different levels of trauma care in general and MT populations (preferably Injury Severity Score of >15) were included. Two independent reviewers performed selection of relevant studies, data extraction, and a quality assessment of included articles. With a random-effects meta-analysis, adjusted and unadjusted pooled effect sizes were calculated for level I versus non-level I trauma centers.
RESULTS: Twenty-two studies were included. Quality of the included studies was good; however, adjustment for comorbidity (32%) and interhospital transfer (38%) was performed less frequently. Nine (60%) of the 15 studies analyzing in-hospital mortality in general trauma populations reported a survival benefit for level I trauma centers. Level I trauma centers were not associated with higher mortality than non-level I trauma centers (adjusted odd ratio, 0.97; 95% confidence interval, 0.61-1.52). Of the 11 studies reporting in-hospital mortality in MT populations, 10 (91%) reported a survival benefit for level I trauma centers. Level I trauma centers were associated with lower mortality than non-level I trauma centers (adjusted odd ratio, 0.77; 95% confidence interval, 0.69-0.87).
CONCLUSION: The association between level of trauma care and in-hospital mortality is evident for MT populations; however, this does not hold for general trauma populations. Level I trauma centers produce improved survival in MT populations. This association could not be proven for nonfatal outcomes in general and MT populations because of inconsistencies in the body of evidence.
LEVEL OF EVIDENCE: Systematic review and meta-analysis, level III.
参考来源
- Van Ditshuizen JC, Van Den Driessche CRL, Sewalt CA, et al. The association between level of trauma care and clinical outcome measures: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2020. PMID: 33017136. doi:10.1097/TA.0000000000002850
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。